Sulfonamide compound or salt thereof
AssigneeTaiho Pharmaceutial Co., Ltd.
InventorsSeiji Miyahara, Hiroyuki Ueno, Shoki Hara, Yoshio Ogino
Life of this patent
Estimating the term…
Loading patent…
AssigneeTaiho Pharmaceutial Co., Ltd.
InventorsSeiji Miyahara, Hiroyuki Ueno, Shoki Hara, Yoshio Ogino
Estimating the term…
The present invention provides a novel sulfonamide compound having a ribonucleotide reductase inhibitory activity or a salt thereof, and a pharmaceutical composition containing the same as an active ingredient. A compound represented by Formula (I) [wherein, X1 represents an oxygen atom or the like; X2 represents an oxygen atom; X3 represents —NH—; X4 represents a hydrogen atom or the like; R1 represents —C(R11)(R12)— or the like; R11 and R12 are the same or different and each represents a hydrogen atom or the like; R2 represents an optionally substituted C6-C14 aromatic hydrocarbon group or the like; R3 represents an optionally substituted C6-C14 aromatic hydrocarbon group or the like; R4 represents a hydrogen atom or the like] or a salt thereof.
A method of treating tumor by inhibiting ribonucleotide reductase in a subject in need thereof, the method comprising administering an effective amount of a compound represented by the following formula (I) or a salt thereof to the subject:
A method of treating tumor comprising administering an effective amount of a compound represented by the following formula (I) or a salt thereof to a subject in need thereof:
Dependencies are inferred from the claim text.